Enzyme discovery may hold key to cancer treatments

A major discovery could open the door to "one-fits-all" cancer drugs that can tackle many different forms of the disease.









Researchers have started to unmask an enzyme that plays a major role in the development of nearly all human cancers.



The work may lead to drugs that de-activate the enzyme, and prevent the uncontrolled cell division that leads to cancer.



Experts have been trying for more than a decade to devise anti-cancer therapies that target the enzyme, telomerase. But they have been thwarted by lack of knowledge about the molecule's construction.



Researchers have now deciphered the enzyme's active region and worked out the most important part of its structure.



The new findings, published in the online edition of the journal Nature, reveal atomic-level details of telomerase showing how it works to replicate the ends of chromosomes - a process critical both to tumour development and ageing.



The results are expected to boost development of telomerase inhibitors.



Study leader Dr Emmanuel Skordalakes, from The Wistar Institute in Philadelphia, US, said: "Telomerase is an ideal target for chemotherapy because it is active in almost all human tumours, but inactive in most normal cells. That means a drug that deactivates telomerase would likely work against all cancers, with few side effects."



Telomerase helps prevent the chromosomes - bundles of DNA which contain the genes - suffering damage and the loss of genetic information during cell division.



The enzyme adds protective "caps" known as "telomeres" to the ends of chromosomes which act like the plastic tips on shoe laces that prevent fraying.



When telomerase is dormant, the telomeres shorten each time a cell divides, eventually leading to genetic instability and cell death. This is a key element of the ageing process.



The enzyme is active in cells that multiple frequently, such as immature cells in embryos, but switched off almost completely in normal adult cells.



However cancer cells often regain the ability to activate telomerase, allowing them to replicate indefinitely, and the enzyme has been implicated in 90 per cent of human tumours.



For this reason deactivating telomerase could halt tumour growth.



Unravelling the mysteries of telomerase may also pave the way to therapies that combat ageing and age-related diseases.



Re-activating dormant telomerase in a controlled, safe way, could theoretically produce younger, healthier and longer living tissue.



Understanding telomerase's structure is the first step towards achieving these goals.



But the molecule is complex, made up of multiple protein domains - three dimensional structures that can function independently of each other - as well as a stretch of the genetic "template" RNA.

Life and Style
ebookNow available in paperback
Latest stories from i100
Have you tried new the Independent Digital Edition apps?

ES Rentals

    Independent Dating
    and  

    By clicking 'Search' you
    are agreeing to our
    Terms of Use.

    iJobs Job Widget
    iJobs General

    Guru Careers: Software Developer / C# Developer

    £40-50K: Guru Careers: We are seeking an experienced Software / C# Developer w...

    Guru Careers: Software Developer

    £35 - 40k + Benefits: Guru Careers: We are seeking a Software Developer (JavaS...

    SThree: Trainee Recruitment Consultant / Resourcer

    £18000 - £23000 per annum + Commission: SThree: As a Trainee Recruitment Consu...

    Ashdown Group: UI Developer - (UI, HTML, CSS, JavaScript, AngularJS)

    £25000 - £40000 per annum: Ashdown Group: UI Developer - (UI, JavaScript, HTML...

    Day In a Page

    Sun, sex and an anthropological study: One British academic's summer of hell in Magaluf

    Sun, sex and an anthropological study

    One academic’s summer of hell in Magaluf
    From Shakespeare to Rising Damp... to Vicious

    Frances de la Tour's 50-year triumph

    'Rising Damp' brought De la Tour such recognition that she could be forgiven if she'd never been able to move on. But at 70, she continues to flourish - and to beguile
    'That Whitsun, I was late getting away...'

    Ian McMillan on the Whitsun Weddings

    This weekend is Whitsun, and while the festival may no longer resonate, Larkin's best-loved poem, lives on - along with the train journey at the heart of it
    Kathryn Williams explores the works and influences of Sylvia Plath in a new light

    Songs from the bell jar

    Kathryn Williams explores the works and influences of Sylvia Plath
    How one man's day in high heels showed him that Cannes must change its 'no flats' policy

    One man's day in high heels

    ...showed him that Cannes must change its 'flats' policy
    Is a quiet crusade to reform executive pay bearing fruit?

    Is a quiet crusade to reform executive pay bearing fruit?

    Dominic Rossi of Fidelity says his pressure on business to control rewards is working. But why aren’t other fund managers helping?
    The King David Hotel gives precious work to Palestinians - unless peace talks are on

    King David Hotel: Palestinians not included

    The King David is special to Jerusalem. Nick Kochan checked in and discovered it has some special arrangements, too
    More people moving from Australia to New Zealand than in the other direction for first time in 24 years

    End of the Aussie brain drain

    More people moving from Australia to New Zealand than in the other direction for first time in 24 years
    Meditation is touted as a cure for mental instability but can it actually be bad for you?

    Can meditation be bad for you?

    Researching a mass murder, Dr Miguel Farias discovered that, far from bringing inner peace, meditation can leave devotees in pieces
    Eurovision 2015: Australians will be cheering on their first-ever entrant this Saturday

    Australia's first-ever Eurovision entrant

    Australia, a nation of kitsch-worshippers, has always loved the Eurovision Song Contest. Maggie Alderson says it'll fit in fine
    Letterman's final Late Show: Laughter, but no tears, as David takes his bow after 33 years

    Laughter, but no tears, as Letterman takes his bow after 33 years

    Veteran talkshow host steps down to plaudits from four presidents
    Ivor Novello Awards 2015: Hozier wins with anti-Catholic song 'Take Me To Church' as John Whittingdale leads praise for Black Sabbath

    Hozier's 'blasphemous' song takes Novello award

    Singer joins Ed Sheeran and Clean Bandit in celebration of the best in British and Irish music
    Tequila gold rush: The spirit has gone from a cheap shot to a multi-billion pound product

    Join the tequila gold rush

    The spirit has gone from a cheap shot to a multi-billion pound product
    12 best statement wallpapers

    12 best statement wallpapers

    Make an impact and transform a room with a conversation-starting pattern
    Paul Scholes column: Does David De Gea really want to leave Manchester United to fight it out for the No 1 spot at Real Madrid?

    Paul Scholes column

    Does David De Gea really want to leave Manchester United to fight it out for the No 1 spot at Real Madrid?